Related Experiment Video
Updated: May 2, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Mutant p53 in cancer: new functions and therapeutic opportunities
Patricia A J Muller1, Karen H Vousden2
1Medical Research Council Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 9HN, UK.
Abstract:
Many different types of cancer show a high incidence of TP53 mutations, leading to the expression of mutant p53 proteins. There is growing evidence that these mutant p53s have both lost wild-type p53 tumor suppressor activity and gained functions that help to contribute to malignant progression. Understanding the functions of mutant p53 will help in the development of new therapeutic approaches that may be useful in a broad range of cancer types.
Insights
TP53 mutations are common in many cancers, causing mutant p53 proteins to lose tumor suppressor functions and gain cancer-promoting activities. Understanding these mutant p53 functions is key for developing new cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- TP53 gene mutations are frequently observed across diverse cancer types.
- Mutant p53 proteins arise from these genetic alterations.
- These mutant proteins possess altered biological functions compared to wild-type p53.
Purpose of the Study:
- To investigate the dual role of mutant p53 proteins in cancer.
- To understand how mutant p53 proteins contribute to malignant progression.
- To identify therapeutic targets based on mutant p53 functions.
Main Methods:
- Analysis of TP53 mutation incidence in various cancers.
- Characterization of mutant p53 protein functions.
- Exploration of gained oncogenic activities of mutant p53.
Main Results:
- Mutant p53 proteins exhibit loss of wild-type tumor suppressor activity.
- Mutant p53 proteins acquire new oncogenic functions.
- These acquired functions actively promote cancer progression.
Conclusions:
- Mutant p53 proteins are critical drivers of malignancy in many cancers.
- Targeting mutant p53 offers a promising strategy for broad-spectrum cancer therapy.
- Further research into mutant p53 functions will guide novel therapeutic development.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

